Trial intelligence / Profile preview

Exosomes vs Minoxidil in Androgenetic Alopecia

NCT07776015Completed

Sponsor
Tanta University
Start
Apr 2023
Primary completion
May 2024
Countries
1
01

Overview

Randomised trial of Exomide in androgenetic alopecia (AGA) (2 arms), sponsored by Tanta University. Primary endpoint: Global Aesthetic Improvement Scale at 6 months. Started Apr 2023; status: completed.

02

Drugs

Exomide
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT07776015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07776015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call